GlassScriptPhysician profile
Scott Thomas Robinson
NPI 1457765265
$4,551.48
in general payments reported to CMS, 2019-2025
10 companies · $2,168 in 2025
The $2,168 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.50 · 2021: $116 · 2022: $1,075 · 2023: $224 · 2024: $939 · 2025: $2,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,311 · Grant: $1,000 · Travel and Lodging: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,311.42 |
| Grant | $1,000.00 |
| Travel and Lodging | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,154.66 | 2021-2025 | Endurant Iis, Valiant Captivia, Venaseal |
| Bolton Medical INC | $1,070.96 | 2022-2024 | Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $452.28 | 2024 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Gore Tag Thoracic Branch Endoprosthesis |
| Abbott Laboratories | $265.02 | 2025 | Esprit, Emboshield Nav6 |
| Boston Scientific Corporation | $171.21 | 2019-2025 | General - Vascular Intervention |
| Stryker Corporation | $156.41 | 2025 | Limflow System |
| Penumbra, INC. | $107.06 | 2024 | Indigo System |
| Smith+Nephew, INC. | $91.13 | 2025 | Stravix, Grafix |
| Endologix LLC | $79.62 | 2023 | Alto Abdominal Stent Graft System |
| Reflow Medical INC | $3.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.